Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment | AVESİS

Middle East Technical University Research Information System

Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment

Copy For Citation

KAHRAMAN D. C., ATALAY R.

24th Biennial Congress of the European Association for Cancer Research, Manchester, England, 9 - 12 July 2016

Publication Type: Conference Paper / Summary Text
City: Manchester
Country: England
Middle East Technical University Affiliated: Yes